Government & Regulation

The U.S. Food and Drug Administration said Dec. 9 it has opened a safety review of injectable RSV drugs used for babies and toddlers, a nationwide regulatory step that could affect pediatric care in the Twin Cities. The agency did not announce a recall but said it is assessing safety reports and will issue guidance if needed.